XML 74 R63.htm IDEA: XBRL DOCUMENT v3.24.2.u1

REVENUES - Principal Activities (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Disaggregation of revenue
Net sales	$ 3,985.8	$ 3,852.1	$ 7,737.7	$ 7,423.7
Allowance for expected return of products	61.0		$ 61.0		$ 71.7
United States | Geographic concentration | Consolidated net sales
Disaggregation of revenue
Percentage of consolidated sales			54.00%	53.00%
Product and equipment sales
Disaggregation of revenue
Net sales	3,173.1	3,104.8	$ 6,159.6	$ 5,981.1
Service and lease sales
Disaggregation of revenue
Net sales	812.7	747.3	1,578.1	1,442.6
Operating segment
Disaggregation of revenue
Net sales	4,020.8	3,855.7	7,782.5	7,436.5
Global Industrial
Disaggregation of revenue
Net sales	1,936.5	1,909.5	3,775.7	3,718.6
Global Industrial | United States
Disaggregation of revenue
Net sales	830.3	806.0	1,624.1	1,599.0
Global Industrial | Europe
Disaggregation of revenue
Net sales	410.6	414.3	785.2	791.7
Global Industrial | Asia Pacific
Disaggregation of revenue
Net sales	230.8	238.9	461.5	467.3
Global Industrial | Latin America
Disaggregation of revenue
Net sales	197.6	182.9	387.2	341.1
Global Industrial | Greater China
Disaggregation of revenue
Net sales	100.5	104.4	198.2	201.3
Global Industrial | India, Middle East and Africa
Disaggregation of revenue
Net sales	112.3	107.8	211.5	212.2
Global Industrial | Canada
Disaggregation of revenue
Net sales	54.4	55.2	108.0	106.0
Global Industrial | Product and equipment sales
Disaggregation of revenue
Net sales	1,702.7	1,683.1	3,315.2	3,275.4
Global Industrial | Service and lease sales
Disaggregation of revenue
Net sales	233.8	226.4	460.5	443.2
Global Industrial | Operating segment
Disaggregation of revenue
Net sales	1,956.0	1,906.4	3,797.7	3,714.6
Global Institutional and Specialty
Disaggregation of revenue
Net sales	1,363.9	1,272.2	2,630.6	2,401.0
Global Institutional and Specialty | United States
Disaggregation of revenue
Net sales	960.9	879.8	1,844.1	1,665.8
Global Institutional and Specialty | Europe
Disaggregation of revenue
Net sales	179.3	174.7	339.8	321.2
Global Institutional and Specialty | Asia Pacific
Disaggregation of revenue
Net sales	59.5	58.4	118.8	115.2
Global Institutional and Specialty | Latin America
Disaggregation of revenue
Net sales	46.8	47.6	96.7	88.9
Global Institutional and Specialty | Greater China
Disaggregation of revenue
Net sales	40.5	40.5	85.2	76.1
Global Institutional and Specialty | India, Middle East and Africa
Disaggregation of revenue
Net sales	17.8	17.2	33.3	31.9
Global Institutional and Specialty | Canada
Disaggregation of revenue
Net sales	59.1	54.0	112.7	101.9
Global Institutional and Specialty | Product and equipment sales
Disaggregation of revenue
Net sales	1,109.9	1,047.2	2,131.3	1,968.0
Global Institutional and Specialty | Service and lease sales
Disaggregation of revenue
Net sales	254.0	225.0	499.3	433.0
Global Institutional and Specialty | Operating segment
Disaggregation of revenue
Net sales	1,372.7	1,273.7	2,643.0	2,404.9
Global Healthcare and Life Sciences
Disaggregation of revenue
Net sales	389.7	390.8	769.6	770.5
Global Healthcare and Life Sciences | United States
Disaggregation of revenue
Net sales	147.6	154.6	297.4	317.1
Global Healthcare and Life Sciences | Europe
Disaggregation of revenue
Net sales	187.0	186.2	371.5	360.6
Global Healthcare and Life Sciences | Asia Pacific
Disaggregation of revenue
Net sales	26.5	22.5	49.9	42.1
Global Healthcare and Life Sciences | Latin America
Disaggregation of revenue
Net sales	5.9	6.6	11.4	12.3
Global Healthcare and Life Sciences | Greater China
Disaggregation of revenue
Net sales	13.8	12.9	23.2	23.7
Global Healthcare and Life Sciences | India, Middle East and Africa
Disaggregation of revenue
Net sales	7.1	6.4	12.5	11.7
Global Healthcare and Life Sciences | Canada
Disaggregation of revenue
Net sales	1.8	1.6	3.7	3.0
Global Healthcare and Life Sciences | Product and equipment sales
Disaggregation of revenue
Net sales	360.5	363.9	713.1	716.5
Global Healthcare and Life Sciences | Service and lease sales
Disaggregation of revenue
Net sales	29.2	26.9	56.5	54.0
Global Healthcare and Life Sciences | Operating segment
Disaggregation of revenue
Net sales	395.0	395.3	777.9	781.4
Global Pest Elimination
Disaggregation of revenue
Net sales	295.7	269.0	561.8	512.4
Global Pest Elimination | United States
Disaggregation of revenue
Net sales	206.8	185.9	388.5	351.8
Global Pest Elimination | Europe
Disaggregation of revenue
Net sales	46.4	42.8	89.6	81.5
Global Pest Elimination | Asia Pacific
Disaggregation of revenue
Net sales	8.0	7.2	15.6	14.1
Global Pest Elimination | Latin America
Disaggregation of revenue
Net sales	15.0	14.2	29.5	27.8
Global Pest Elimination | Greater China
Disaggregation of revenue
Net sales	14.9	14.5	29.6	28.5
Global Pest Elimination | India, Middle East and Africa
Disaggregation of revenue
Net sales	1.7	1.7	3.4	3.6
Global Pest Elimination | Canada
Disaggregation of revenue
Net sales	2.9	2.7	5.6	5.1
Global Pest Elimination | Service and lease sales
Disaggregation of revenue
Net sales	295.7	269.0	561.8	512.4
Global Pest Elimination | Operating segment
Disaggregation of revenue
Net sales	$ 297.1	269.7	$ 563.9	514.3
Corporate
Disaggregation of revenue
Net sales		10.6		21.2
Corporate | United States
Disaggregation of revenue
Net sales		9.6		19.2
Corporate | Europe
Disaggregation of revenue
Net sales		0.7		1.4
Corporate | Asia Pacific
Disaggregation of revenue
Net sales		0.1		0.1
Corporate | Latin America
Disaggregation of revenue
Net sales		0.2		0.5
Corporate | Product and equipment sales
Disaggregation of revenue
Net sales		10.6		21.2
Corporate | Operating segment
Disaggregation of revenue
Net sales		$ 10.6		$ 21.3

X

- Definition

This element represents the portion of the allowance for doubtful accounts receivable representing the expected return of products shipped and credits related to pricing or quantities shipped.

+ References

No definition available.

+ Details

Name:	ecl_AllowanceForDoubtfulAccountsReturnsCredits
Namespace Prefix:	ecl_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-21

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-20

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-20

+ Details

Name:	us-gaap_ConcentrationRiskPercentage1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

+ Details

Name:	us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 924
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-4

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	srt_StatementGeographicalAxis=country_US
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConcentrationRiskByBenchmarkAxis=ecl_SalesRevenueTotalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=ecl_ProductAndEquipmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=ecl_ServiceAndLeaseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=ecl_GlobalIndustrialMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=srt_EuropeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=srt_AsiaPacificMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=srt_LatinAmericaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=country_CN
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=ecl_IndiaMiddleEastAndAfricaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=country_CA
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=ecl_GlobalInstitutionalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=ecl_GlobalHealthcareAndLifeSciencesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=ecl_GlobalPestEliminationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: